News Automatic artificial pancreas shows promise in trial Experimental device requires no user input at all.
News J&J hopes FDA cardio label will limit Invokana damage Diabetes drug has been hit by amputation warning on label.
News No cardio protection indication for Novo's semaglutide - yet Danish pharma plans outcome trial to confirm benefits in SUSTAIN 6
News Novo aims for GLP-1 sales growth in China Novo expects Victoza and semaglutide to gain momentum.
News Novo highlights key 'hypo' data from Tresiba at EASD Novo hopes data will justify higher price compared with rival.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
